Mozart Therapeutics

Seattle, Washington, USA

Mozart Therapeutics develops therapies for celiac disease and other immune-related conditions.

Facts

HQ
Seattle, Washington, USA
Sectors
Biotechnology, Biopharma, Immunology
Founded
2023
Type
Corporation Seattle business license
Registered name
Mozart Therapeutics Inc Seattle business license
Stage
Series C

Is this your organization? Claim it

Recent coverage

Front-page news, podcasts and videos about Mozart Therapeutics

See all 7

People

  • Katie Fanning Executive, President and Chief Executive Officer

Questions about Mozart Therapeutics

What is Mozart Therapeutics?

Mozart Therapeutics is a startup that develops therapies for celiac disease and other immune-related conditions, based in Seattle, Washington, USA.

What is Mozart Therapeutics known for?

GeekWire reported in June 2023 that Mozart Therapeutics was advancing the autoimmune disease drug MTX-101, with an FDA IND planned for early 2024.

What has Mozart Therapeutics been in the news for?

GeekWire reported in June 2023 that Mozart Therapeutics was advancing the autoimmune disease drug MTX-101, with an FDA IND planned for early 2024.

Who are the people behind Mozart Therapeutics?

Katie Fanning is president and chief executive officer of Mozart Therapeutics.

Who invested in Mozart Therapeutics, and how much has it raised?

Members of Seattle Flow see Mozart Therapeutics' funding rounds, amounts and investors on its Funding tab. Joining is free.

Where is Mozart Therapeutics based?

Mozart Therapeutics is based in Seattle, Washington, USA.